Setting a more ambitious target for mean arterial pressure (MAP) through pharmacologic support in patients with acute MI complicated by cardiogenic shock (AMICS) appears to safely reduce myocardial ...
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- ...
Ischemic cardiogenic shock is a complex, self-perpetuating pathological process that frequently causes death irrespective of medical therapy. Early definition of coronary anatomy is a pivotal step ...
Which vasopressors should be given through a central line? Can certain vasopressors be given through a peripheral intravenous (IV) line? Inotropes used intravenously for the treatment of hypotension ...
WARRINGTON, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a diversified company focused on revenue generation in multiple growing ...
You ask a good question. These patients do present with elevated CK levels, but there has been no systematic investigation into the pathophysiology of this phenomenon. However, there is suggestive ...
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
WARRINGTON, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue-generating company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback